Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII
|
May 26, 2022
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
Pascale Palassin, Alexandre T J Maria, Chayma Ladhari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2015
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis
Alexandre T J Maria, Karine Toupet, Claire Bony, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2026
Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series
Stéphanie Hermabessiere, Benjamin Jauzelon, Steven Marmain, et al.
European Journal of Neurology
|
November 11, 2022
Immune-mediated diseases involving central and peripheral nervous systems
Aurelie Leboyan, Florence Esselin, Anne-Laure Bascou, et al.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Rik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII
|
May 26, 2022
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
Pascale Palassin, Alexandre T J Maria, Chayma Ladhari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2015
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis
Alexandre T J Maria, Karine Toupet, Claire Bony, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2026
Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series
Stéphanie Hermabessiere, Benjamin Jauzelon, Steven Marmain, et al.
European Journal of Neurology
|
November 11, 2022
Immune-mediated diseases involving central and peripheral nervous systems
Aurelie Leboyan, Florence Esselin, Anne-Laure Bascou, et al.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Rik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Page
of 2